This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Screening and diagnosis of male breast cancer

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

There are no formal recommendations or guidelines on screening and diagnosis of male breast cancer (1).

screening

  • there is no practical role of mammographic screening of all men due to the low incidence in the general population

  • for individuals with an increased risk of developing breast cancer the following screening and surveillance are recommended:
    • monthly breast self-examination
    • semi-annual clinical breast examination
    • baseline mammography followed by annual mammography if gynecomastia and/or breast density seen on baseline (2)


diagnosis

  • mammography
    • useful in differentiating malignant breast disease form gynaecomastia
    • sensitivity and specificity of mammography for the diagnosis of MBC is 92% and 90%, respectively
  • ultrasound
    • shows an irregular hypoechoic solid mass
    • a complex cystic mass also is suspicious
    • should include the ipsilateral axilla and any abnormal nodes should be sampled by fine-needle aspiration or core biopsy (3)
  • ultrasound-guided core biopsy
    • only method to obtain a definitive diagnosis

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.